SBIA
SPPI

Sheaff Brock Investment Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,000
Closed -$2.95K – 555
2022
Q4 		$2.95K Buy
+8,000
New +$3.37K ﹤0.01% 509
2022
Q3 		– Hold
0
– – – 493

Sheaff Brock Investment Advisors's SPPI Position: Q3 2023 in Review

Sheaff Brock Investment Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 38,200 shares — an estimated $36.7K sold.

Sheaff Brock Investment Advisors first reported a position in SPPI in Q3 2021 and held it in 8 quarters. The position peaked at $36.7K in Q2 2023. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • Sheaff Brock Investment Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 38,200 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $36.7K.
  • Sheaff Brock Investment Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q3 2021 and held it in 8 quarters.
  • Sheaff Brock Investment Advisors's Spectrum Pharmaceuticals Inc position peaked at $36.7K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on Sheaff Brock Investment Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.